Research Output 1979 2018

2018
6 Citations (Scopus)

Phase 1/2 trial of temsirolimus and sorafenib in the treatment of patients with recurrent glioblastoma: North Central Cancer Treatment Group Study/Alliance N0572

Schiff, D., Jaeckle, K., Anderson, S. K., Galanis, E., Giannini, C., Buckner, J. C., Stella, P., Flynn, P. J., Erickson, B. J., Schwerkoske, J. F., Kaluza, V., Twohy, E., Dancey, J., Wright, J. & Sarkaria, J. N., Apr 1 2018, In : Cancer. 124, 7, p. 1455-1463 9 p.

Research output: Contribution to journalArticle

Glioblastoma
Vascular Endothelial Growth Factor A
Neoplasms
Maximum Tolerated Dose
temozolomide
6 Citations (Scopus)

Phase I/II trial of vorinostat combined with temozolomide and radiation therapy for newly diagnosed glioblastoma: Results of Alliance N0874/ABTC 02

Galanis, E., Keith Anderson, S., Miller, C. R., Sarkaria, J. N., Jaeckle, K., Buckner, J. C., Ligon, K. L., Ballman, K. V., Moore, D. F., Nebozhyn, M., Loboda, A., Schiff, D., Ahluwalia, M. S., Lee, E. Q., Gerstner, E. R., Lesser, G. J., Prados, M., Grossman, S. A., Cerhan, J., Giannini, C. & 1 others, Wen, P. Y., Mar 27 2018, In : Neuro-Oncology. 20, 4, p. 546-556 11 p.

Research output: Contribution to journalArticle

temozolomide
Glioblastoma
Radiotherapy
Neutropenia
Disease-Free Survival
1 Citation (Scopus)

Treatment of a glioblastoma multiforme dural metastasis with stereotactic radiosurgery: A case report and select review of the literature

Hintenlang, L. L., Miller, D. H., Kaleem, T., Patel, N., May, B. C., Tzou, K. S., Vallow, L. A., Buskirk, S. J., Miller, R. C., Ko, S. J., Jaeckle, K., Trifiletti, D. M. & Peterson, J. L., Feb 1 2018, In : Journal of Clinical Neuroscience. 48, p. 118-121 4 p.

Research output: Contribution to journalArticle

Radiosurgery
Glioblastoma
Neoplasm Metastasis
temozolomide
Therapeutics
2017
5 Citations (Scopus)

Diffuse midline gliomas with subclonal H3F3A K27M mutation and mosaic H3.3 K27M mutant protein expression

Lopez, G. Y., Oberheim Bush, N. A., Phillips, J. J., Bouffard, J. P., Moshel, Y. A., Jaeckle, K., Kleinschmidt-DeMasters, B. K., Rosenblum, M. K., Perry, A. & Solomon, D. A., Dec 1 2017, In : Acta Neuropathologica. 134, 6, p. 961-963 3 p.

Research output: Contribution to journalLetter

52 Citations (Scopus)

Leptomeningeal metastases: A RANO proposal for response criteria

Chamberlain, M., Junck, L., Brandsma, D., Soffietti, R., Rudà, R., Raizer, J., Boogerd, W., Taillibert, S., Groves, M. D., Le Rhun, E., Walker, J., Van Den Bent, M., Wen, P. Y. & Jaeckle, K. A., Apr 1 2017, In : Neuro-Oncology. 19, 4, p. 484-492 9 p.

Research output: Contribution to journalReview article

Neoplasm Metastasis
Cell Biology
Flow Cytometry
Neuroimaging
Disease Progression
24 Citations (Scopus)

Phase III randomized study of radiation and temozolomide versus radiation and nitrosourea therapy for anaplastic astrocytoma: Results of nrg oncology RTOG 9813

Chang, S., Zhang, P., Cairncross, J. G., Gilbert, M. R., Bahary, J. P., Dolinskas, C. A., Chakravarti, A., Aldape, K. D., Bell, E. H., Schiff, D., Jaeckle, K., Brown, P. D., Barger, G. R., Werner-Wasik, M., Shih, H., Brachman, D., Penas-Prado, M., Robins, H. I., Belanger, K., Schultz, C. & 2 others, Hunter, G. & Mehta, M., Jan 1 2017, In : Neuro-Oncology. 19, 2, p. 252-258 7 p.

Research output: Contribution to journalArticle

temozolomide
Astrocytoma
Radiotherapy
Radiation
Survival
14 Citations (Scopus)

Stereotactic Radiosurgery With or Without Whole-Brain Radiation Therapy for Limited Brain Metastases: A Secondary Analysis of the North Central Cancer Treatment Group N0574 (Alliance) Randomized Controlled Trial

Churilla, T. M., Ballman, K. V., Brown, P. D., Twohy, E. L., Jaeckle, K., Farace, E., Cerhan, J. H., Anderson, S. K., Carrero, X. W., Garces, Y. I., Barker, F. G., Deming, R., Dixon, J. G., Burri, S. H., Chung, C., Ménard, C., Stieber, V. W., Pollock, B. E., Galanis, E., Buckner, J. C. & 1 others, Asher, A. L., Dec 1 2017, In : International Journal of Radiation Oncology Biology Physics. 99, 5, p. 1173-1178 6 p.

Research output: Contribution to journalArticle

Radiosurgery
metastasis
brain
radiation therapy
Radiotherapy
22 Citations (Scopus)

The Neurologic Assessment in Neuro-Oncology (NANO) scale: A tool to assess neurologic function for integration into the Response Assessment in Neuro-Oncology (RANO) criteria

Nayak, L., Deangelis, L. M., Brandes, A. A., Peereboom, D. M., Galanis, E., Lin, N. U., Soffietti, R., MacDonald, D. R., Chamberlain, M., Perry, J., Jaeckle, K., Mehta, M., Stupp, R., Muzikansky, A., Pentsova, E., Cloughesy, T., Iwamoto, F. M., Tonn, J. C., Vogelbaum, M. A., Wen, P. Y. & 2 others, Van Den Bent, M. J. & Reardon, D. A., May 1 2017, In : Neuro-Oncology. 19, 5, p. 625-635 11 p.

Research output: Contribution to journalArticle

Nervous System
Outcome Assessment (Health Care)
Observer Variation
Brain Neoplasms
Glioma
2016
353 Citations (Scopus)

Effect of radiosurgery alone vs radiosurgery with whole brain radiation therapy on cognitive function in patients with 1 to 3 brain metastases a randomized clinical trial

Brown, P. D., Jaeckle, K., Ballman, K. V., Farace, E., Cerhan, J. H., Keith Anderson, S., Carrero, X. W., Barker, F. G., Deming, R., Burri, S. H., Ménard, C., Chung, C., Stieber, V. W., Pollock, B. E., Galanis, E., Buckner, J. C. & Asher, A. L., Jul 26 2016, In : JAMA - Journal of the American Medical Association. 316, 4, p. 401-409 9 p.

Research output: Contribution to journalArticle

Radiosurgery
Cognition
Radiotherapy
Randomized Controlled Trials
Neoplasm Metastasis
2015
49 Citations (Scopus)

A phase II trial of everolimus, temozolomide, and radiotherapy in patients with newly diagnosed glioblastoma: NCCTG N057K

Ma, D. J., Galanis, E., Anderson, S. K., Schiff, D., Kaufmann, T. J., Peller, P. J., Giannini, C., Brown, P. D., Uhm, J. H., McGraw, S., Jaeckle, K., Flynn, P. J., Ligon, K. L., Buckner, J. C. & Sarkaria, J. N., Sep 1 2015, In : Neuro-Oncology. 17, 9, p. 1261-1269 9 p.

Research output: Contribution to journalArticle

temozolomide
Glioblastoma
Radiotherapy
Sirolimus
Phosphatidylinositol 3-Kinase
7 Citations (Scopus)

Quantification of the impact of enzyme-inducing antiepileptic drugs on irinotecan pharmacokinetics and SN-38 exposure

Berg, A. K., Buckner, J. C., Galanis, E., Jaeckle, K., Ames, M. M. & Reid, J. M., Nov 1 2015, In : Journal of Clinical Pharmacology. 55, 11, p. 1303-1312 10 p.

Research output: Contribution to journalArticle

irinotecan
Anticonvulsants
Pharmacokinetics
Enzymes
Glioma
2014
1139 Citations (Scopus)

A randomized trial of bevacizumab for newly diagnosed glioblastoma

Gilbert, M. R., Dignam, J. J., Armstrong, T. S., Wefel, J. S., Blumenthal, D. T., Vogelbaum, M. A., Colman, H., Chakravarti, A., Pugh, S., Won, M., Jeraj, R., Brown, P. D., Jaeckle, K. A., Schiff, D., Stieber, V. W., Brachman, D. G., Werner-Wasik, M., Tremont-Lukats, I. W., Sulman, E. P., Aldape, K. D. & 2 others, Curran, W. J. & Mehta, M. P., Jan 1 2014, In : New England Journal of Medicine. 370, 8, p. 699-708 10 p.

Research output: Contribution to journalArticle

Glioblastoma
temozolomide
Radiotherapy
Placebos
Risk Reduction Behavior
69 Citations (Scopus)

Leptomeningeal metastasis: A Response Assessment in Neuro-Oncology critical review of endpoints and response criteria of published randomized clinical trials

Chamberlain, M., Soffietti, R., Raizer, J., Rudà, R., Brandsma, D., Boogerd, W., Taillibert, S., Groves, M. D., Le Rhun, E., Junck, L., Van Den Bent, M., Wen, P. Y. & Jaeckle, K. A., Sep 2014, In : Neuro-Oncology. 16, 9, p. 1176-1185 10 p.

Research output: Contribution to journalReview article

Randomized Controlled Trials
Neoplasm Metastasis
Drug Therapy
Therapeutics
Cytarabine
8 Citations (Scopus)

Oligodendroglial tumors

Jaeckle, K., Jan 1 2014, In : Seminars in Oncology. 41, 4, p. 468-477 10 p.

Research output: Contribution to journalArticle

Neoplasms
Therapeutics
Radiation Oncology
Neuroglia
Radiotherapy
2013
396 Citations (Scopus)

Dose-dense temozolomide for newly diagnosed glioblastoma: A randomized phase III clinical trial

Gilbert, M. R., Wang, M., Aldape, K. D., Stupp, R., Hegi, M. E., Jaeckle, K., Armstrong, T. S., Wefel, J. S., Won, M., Blumenthal, D. T., Mahajan, A., Schultz, C. J., Erridge, S., Baumert, B., Hopkins, K. I., Tzuk-Shina, T., Brown, P. D., Chakravarti, A., Curran, W. J. & Mehta, M. P., Nov 10 2013, In : Journal of Clinical Oncology. 31, 32, p. 4085-4091 7 p.

Research output: Contribution to journalArticle

temozolomide
Phase III Clinical Trials
Methyltransferases
Glioblastoma
Randomized Controlled Trials
74 Citations (Scopus)

Phase II study of bevacizumab in combination with sorafenib in recurrent glioblastoma (N0776): A North Central Cancer Treatment Group Trial

Galanis, E., Anderson, S. K., Lafky, J. M., Uhm, J. H., Giannini, C., Kumar, S. K., Kimlinger, T. K., Northfelt, D. W., Flynn, P. J., Jaeckle, K., Kaufmann, T. J. & Buckner, J. C., Sep 1 2013, In : Clinical Cancer Research. 19, 17, p. 4816-4823 8 p.

Research output: Contribution to journalArticle

Glioblastoma
Vascular Endothelial Growth Factor A
Neoplasms
Single Nucleotide Polymorphism
Biomarkers
9 Citations (Scopus)

RTOG 9802: Good wines need aging

Van Den Bent, M. J., Jaeckle, K., Baumert, B. & Wick, W., Feb 10 2013, In : Journal of Clinical Oncology. 31, 5, p. 653-654 2 p.

Research output: Contribution to journalLetter

Antineoplastic Combined Chemotherapy Protocols
Supratentorial Neoplasms
Adjuvant Chemoradiotherapy
Wine
Glioma
2012

Low Grade Gliomas and Oligodendrogliomas in Adulthood

Johnson, D. R. & Jaeckle, K., Feb 29 2012, Neuro-oncology: First Edition. Blackwell Publishing Ltd., p. 76-85 10 p.

Research output: Chapter in Book/Report/Conference proceedingChapter

Oligodendroglioma
Glioma
Natural History
Brain Neoplasms
Young Adult

Neurological complications of plasma cell disorders

Drappatz, J. & Jaeckle, K., Jan 1 2012, Lymphoma and Leukemia of the Nervous System. Springer New York, p. 299-312 14 p.

Research output: Chapter in Book/Report/Conference proceedingChapter

Plasma Cells
Waldenstrom Macroglobulinemia
Immunoglobulin Fragments
Paraproteinemias
Plasmacytoma
116 Citations (Scopus)

Phase II trial of vorinostat in combination with bortezomib in recurrent glioblastoma: A north central cancer treatment group study

Friday, B. B., Anderson, S. K., Buckner, J., Yu, C., Giannini, C., Geoffroy, F., Schwerkoske, J., Mazurczak, M., Gross, H., Pajon, E., Jaeckle, K. & Galanis, E., Feb 1 2012, In : Neuro-Oncology. 14, 2, p. 215-221 7 p.

Research output: Contribution to journalArticle

Glioblastoma
Neoplasms
Proteasome Inhibitors
Histone Deacetylase Inhibitors
Therapeutics
7 Citations (Scopus)

Primary central nervous system B cell lymphoma with features intermediate between diffuse large B cell lymphoma and burkitt lymphoma

Jiang, L., Li, Z., Finn, L. E., Personnet, D. A., Edenfield, B., Foran, J. M., Jaeckle, K., Reimer, R., Menke, D. M., Ketterling, R. P. & Tun, H. W., Feb 13 2012, In : International Journal of Clinical and Experimental Pathology. 5, 1, p. 72-76 5 p.

Research output: Contribution to journalArticle

Burkitt Lymphoma
Lymphoma, Large B-Cell, Diffuse
B-Cell Lymphoma
Central Nervous System
Lymphoma
2011
2 Citations (Scopus)

Metastases involving spinal cord, roots, and plexus

Jaeckle, K., Jan 1 2011, In : CONTINUUM Lifelong Learning in Neurology. 17, 4, p. 855-871 17 p.

Research output: Contribution to journalReview article

Spinal Nerve Roots
Spinal Cord
Neoplasm Metastasis
Peripheral Nerves
Pain
55 Citations (Scopus)

North central cancer treatment group Phase i trial N057K of everolimus (RAD001) and temozolomide in combination with radiation therapy in patients with newly diagnosed glioblastoma multiforme

Sarkaria, J. N., Galanis, E., Wu, W., Peller, P. J., Giannini, C., Brown, P. D., Uhm, J. H., McGraw, S., Jaeckle, K. & Buckner, J. C., Oct 1 2011, In : International Journal of Radiation Oncology Biology Physics. 81, 2, p. 468-475 8 p.

Research output: Contribution to journalArticle

temozolomide
Glioblastoma
radiation therapy
Radiotherapy
cancer
84 Citations (Scopus)

Phase II evaluation of gefitinib in patients with newly diagnosed grade 4 astrocytoma: Mayo/north central cancer treatment group study n0074

Uhm, J. H., Ballman, K. V., Wu, W., Giannini, C., Krauss, J. C., Buckner, J. C., James, C. D., Scheithauer, B. W., Behrens, R. J., Flynn, P. J., Schaefer, P. L., Dakhill, S. R. & Jaeckle, K. A., Jun 1 2011, In : International Journal of Radiation Oncology Biology Physics. 80, 2, p. 347-353 7 p.

Research output: Contribution to journalArticle

Astrocytoma
Glioblastoma
grade
cancer
evaluation
266 Citations (Scopus)

Response assessment in neuro-oncology (a report of the RANO group): Assessment of outcome in trials of diffuse low-grade gliomas

Van den Bent, M. J., Wefel, J. S., Schiff, D., Taphoorn, M. J. B., Jaeckle, K., Junck, L., Armstrong, T., Choucair, A., Waldman, A. D., Gorlia, T., Chamberlain, M., Baumert, B. G., Vogelbaum, M. A., Macdonald, D. R., Reardon, D. A., Wen, P. Y., Chang, S. M. & Jacobs, A. H., Jun 1 2011, In : The Lancet Oncology. 12, 6, p. 583-593 11 p.

Research output: Contribution to journalReview article

Glioma
Outcome Assessment (Health Care)
Survival
Cognition
Neoplasms
52 Citations (Scopus)

Transformation of low grade glioma and correlation with outcome: An NCCTG database analysis

Jaeckle, K. A., Decker, P. A., Ballman, K. V., Flynn, P. J., Giannini, C., Scheithauer, B. W., Jenkins, R. B. & Buckner, J. C., Aug 1 2011, In : Journal of Neuro-Oncology. 104, 1, p. 253-259 7 p.

Research output: Contribution to journalReview article

Glioma
Glioblastoma
Databases
Recurrence
Astrocytoma
2010
54 Citations (Scopus)

Combination of temsirolimus (CCI-779) with chemoradiation in newly diagnosed glioblastoma multiforme (GBM) (NCCTG trial N027D) is associated with increased infectious risks

Sarkaria, J. N., Galanis, E., Wu, W., Dietz, A. B., Kaufmann, T. J., Gustafson, M. P., Brown, P. D., Uhm, J. H., Rao, R. D., Doyle, L., Giannini, C., Jaeckle, K. A. & Buckner, J. C., Nov 15 2010, In : Clinical Cancer Research. 16, 22, p. 5573-5580 8 p.

Research output: Contribution to journalArticle

temozolomide
Glioblastoma
Radiation
Antibiotic Prophylaxis
Chemoradiotherapy

Correlation of enzyme-inducing anticonvulsant use with outcome of patients with glioblastoma

Jaeckle, K. A., Ballman, K., Furth, A. & Buckner, J. C., Apr 1 2010, In : Neurology. 74, 16, 1 p.

Research output: Contribution to journalLetter

Glioblastoma
Anticonvulsants
Enzymes
8 Citations (Scopus)

Correlation of enzyme-inducing anticonvulsant use with outcome of patients with glioblastoma [2]

Jaeckle, K., Ballman, K., Furth, A. & Buckner, J. C., Jan 1 2010, In : Neurology. 74, 16, p. 1329-1330 2 p.

Research output: Contribution to journalLetter

Enzyme Activation
Glioblastoma
Drug Interactions
Reproducibility of Results
Brain Neoplasms
50 Citations (Scopus)

Joint NCCTG and NABTC prognostic factors analysis for high-grade recurrent glioma

Wu, W., Lamborn, K. R., Buckner, J. C., Novotny, P. J., Chang, S. M., O'Fallon, J. R., Jaeckle, K. A. & Prados, M. D., Feb 1 2010, In : Neuro-Oncology. 12, 2, p. 164-172 9 p.

Research output: Contribution to journalArticle

Brain Neoplasms
Glioma
Statistical Factor Analysis
Joints
Disease-Free Survival
63 Citations (Scopus)

Neurologic manifestations of neoplastic and radiation-induced plexopathies

Jaeckle, K. A., Jul 6 2010, In : Seminars in Neurology. 30, 3, p. 254-262 9 p.

Research output: Contribution to journalReview article

Neurologic Manifestations
Pain Management
Radiation
Brachial Plexus Neuropathies
Neoplasms
5 Citations (Scopus)

Phase II NCCTG trial of RT + irinotecan and adjuvant BCNU plus irinotecan for newly diagnosed GBM

Jaeckle, K., Ballman, K. V., Giannini, C., Schomberg, P. J., Ames, M. M., Reid, J. M., McGovern, R. M., Safgren, S. L., Galanis, E., Uhm, J. H., Brown, P. D., Hammack, J. E., Arusell, R., Nikcevich, D. A., Morton, R. F., Wender, D. B. & Buckner, J. C., Aug 1 2010, In : Journal of Neuro-Oncology. 99, 1, p. 73-80 8 p.

Research output: Contribution to journalArticle

irinotecan
Carmustine
Anticonvulsants
Alleles
Area Under Curve
2009
74 Citations (Scopus)

Correlation of enzyme-inducing anticonvulsant use with outcome of patients with glioblastoma

Jaeckle, K. A., Ballman, K., Furth, A. & Buckner, J. C., Oct 2009, In : Neurology. 73, 15, p. 1207-1213 7 p.

Research output: Contribution to journalArticle

Glioblastoma
Anticonvulsants
Enzymes
Disease-Free Survival
Cytochrome P-450 Enzyme System
24 Citations (Scopus)

Phase II trial of two different irinotecan schedules with pharmacokinetic analysis in patients with recurrent glioma: North Central Cancer Treatment Group results

Santisteban, M., Buckner, J. C., Reid, J. M., Wu, W., Scheithauer, B. W., Ames, M. M., Felten, S. J., Nikcevich, D. A., Wiesenfeld, M., Jaeckle, K. & Galanis, E., Jan 1 2009, In : Journal of Neuro-Oncology. 92, 2, p. 165-175 11 p.

Research output: Contribution to journalArticle

irinotecan
Glioma
Appointments and Schedules
Pharmacokinetics
Neoplasms
222 Citations (Scopus)

Phase II trial of Vorinostat in recurrent glioblastoma multiforme: A north central cancer treatment group study

Galanis, E., Jaeckle, K., Maurer, M. J., Reid, J. M., Ames, M. M., Hardwick, J. S., Reilly, J. F., Loboda, A., Nebozhyn, M., Fantin, V. R., Richon, V. M., Scheithauer, B., Giannini, C., Flynn, P. J., Moore, D. F., Zwiebel, J. & Buckner, J. C., Apr 20 2009, In : Journal of Clinical Oncology. 27, 12, p. 2052-2058 7 p.

Research output: Contribution to journalArticle

Glioblastoma
Neoplasms
Therapeutics
Histones
Acetylation
2008
3 Citations (Scopus)

North Central Cancer Treatment Group-Achievements and Perspectives

Grothey, A., Adjei, A. A., Alberts, S. R., Perez, E. A., Jaeckle, K., Loprinzi, C. L., Sargent, D. J., Sloan, J. A. & Buckner, J. C., Oct 1 2008, In : Seminars in Oncology. 35, 5, p. 530-544 15 p.

Research output: Contribution to journalArticle

Neoplasms
Therapeutics
Quality of Life
Clinical Trials
Research
114 Citations (Scopus)

Pathway analysis of primary central nervous system lymphoma

Tun, H. W., Personett, D., Baskerville, K. A., Menke, D. M., Jaeckle, K. A., Kreinest, P., Edenfield, B., Zubair, A. C., O'Neill, B. P., Lai, W. R., Park, P. J. & McKinney, M., Mar 15 2008, In : Blood. 111, 6, p. 3200-3210 11 p.

Research output: Contribution to journalArticle

Neurology
Lymphoma
Central Nervous System
Extracellular Matrix
Gene expression
185 Citations (Scopus)

Phase I/II trial of erlotinib and temozolomide with radiation therapy in the treatment of newly diagnosed glioblastoma multiforme: North central cancer treatment group study N0177

Brown, P. D., Krishnan, S., Sarkaria, J. N., Wu, W., Jaeckle, K., Uhm, J. H., Geoffroy, F. J., Arusell, R., Kitange, G., Jenkins, R. B., Kugler, J. W., Morton, R. F., Rowland, K. M., Mischel, P., Yong, W. H., Scheithauer, B. W., Schiff, D., Giannini, C. & Buckner, J. C., Dec 1 2008, In : Journal of Clinical Oncology. 26, 34, p. 5603-5609 7 p.

Research output: Contribution to journalArticle

temozolomide
Glioblastoma
Radiotherapy
Epidermal Growth Factor Receptor
Neoplasms
2007
2 Citations (Scopus)

Status epilepticus in patients with CNS metastases [4]

Blitshteyn, S. & Jaeckle, K. A., Jan 1 2007, In : Archives of Neurology. 64, 6, 1 p.

Research output: Contribution to journalLetter

Status Epilepticus
Neoplasm Metastasis
221 Citations (Scopus)

The relationship between six-month progression-free survival and 12-month overall survival end points for phase II trials in patients with glioblastoma multiforme

Ballman, K. V., Buckner, J. C., Brown, P. D., Giannini, C., Flynn, P. J., LaPlant, B. R. & Jaeckle, K. A., Jan 1 2007, In : Neuro-Oncology. 9, 1, p. 29-38 10 p.

Research output: Contribution to journalArticle

Glioblastoma
Disease-Free Survival
Survival
Radiotherapy
Proportional Hazards Models
2006
153 Citations (Scopus)

A phase 2 trial of irinotecan (CPT-11) in patients with recurrent malignant glioma: A North American Brain Tumor Consortium study

Prados, M. D., Lamborn, K., Yung, W. K. A., Jaeckle, K., Robins, H. I., Mehta, M., Fine, H. A., Wen, P. Y., Cloughesy, T., Chang, S., Nicholas, M. K., Schiff, D., Greenberg, H., Junck, L., Fink, K., Hess, K. & Kuhn, J., Apr 1 2006, In : Neuro-Oncology. 8, 2, p. 189-193 5 p.

Research output: Contribution to journalArticle

irinotecan
Brain Neoplasms
Glioma
Glioblastoma
Anticonvulsants
51 Citations (Scopus)

Current strategies in treatment of oligodendroglioma: Evolution of molecular signatures of response

Jaeckle, K., Ballman, K. V., Rao, R. D., Jenkins, R. B. & Buckner, J. C., Mar 10 2006, In : Journal of Clinical Oncology. 24, 8, p. 1246-1252 7 p.

Research output: Contribution to journalReview article

Oligodendroglioma
Molecular Evolution
Radiotherapy
temozolomide
Lomustine
62 Citations (Scopus)

Detrimental effects of tumor progression on cognitive function of patients with high-grade glioma

Brown, P. D., Jensen, A. W., Felten, S. J., Ballman, K. V., Schaefer, P. L., Jaeckle, K. A., Cerhan, J. H. & Buckner, J. C., Dec 1 2006, In : Journal of Clinical Oncology. 24, 34, p. 5427-5433 7 p.

Research output: Contribution to journalArticle

Glioma
Cognition
Neoplasms
Brain Neoplasms
Radiation
54 Citations (Scopus)

Neoplastic Meningitis From Systemic Malignancies: Diagnosis, Prognosis and Treatment

Jaeckle, K., Jun 1 2006, In : Seminars in Oncology. 33, 3, p. 312-323 12 p.

Research output: Contribution to journalArticle

Meningitis
Survival
Neoplasms
Cerebrospinal Fluid
Breast Neoplasms
20 Citations (Scopus)

Nonconvulsive status epilepticus in metastatic CNS disease

Blitshteyn, S. & Jaeckle, K., Apr 1 2006, In : Neurology. 66, 8, p. 1261-1263 3 p.

Research output: Contribution to journalArticle

Status Epilepticus
Central Nervous System Diseases
Anticonvulsants
Differential Diagnosis
Therapeutics
17 Citations (Scopus)

Ototoxicity of cisplatin plus standard radiation therapy vs. accelerated radiation therapy in glioblastoma patients

Marshall, N. E., Ballman, K. V., Michalak, J. C., Schomberg, P. J., Burton, G. V., Sandler, H. M., Cascino, T. L., Jaeckle, K. & Buckner, J. C., May 1 2006, In : Journal of Neuro-Oncology. 77, 3, p. 315-320 6 p.

Research output: Contribution to journalArticle

Glioblastoma
Cisplatin
Carmustine
Radiotherapy
Hearing Loss
42 Citations (Scopus)

Phase II trial of temozolomide plus marimastat for recurrent anaplastic gliomas: A relationship among efficacy, joint toxicity and anticonvulsant status

Groves, M. D., Puduvalli, V. K., Conrad, C. A., Gilbert, M. R., Yung, W. K. A., Jaeckle, K., Liu, V., Hess, K. R., Aldape, K. D. & Levin, V. A., Oct 1 2006, In : Journal of Neuro-Oncology. 80, 1, p. 83-90 8 p.

Research output: Contribution to journalArticle

temozolomide
Glioma
Anticonvulsants
Joints
Confidence Intervals
75 Citations (Scopus)

Phase I trial of erlotinib with radiation therapy in patients with glioblastoma multiforme: Results of North Central Cancer Treatment Group protocol N0177

Krishnan, S., Brown, P. D., Ballman, K. V., Fiveash, J. B., Uhm, J. H., Giannini, C., Jaeckle, K., Geoffroy, F. J., Nabors, L. B. & Buckner, J. C., Jul 15 2006, In : International Journal of Radiation Oncology Biology Physics. 65, 4, p. 1192-1199 8 p.

Research output: Contribution to journalArticle

Antineoplastic Protocols
Glioblastoma
radiation therapy
Radiotherapy
cancer
2005
2 Citations (Scopus)

Improving the outcome of patients with leptomeningeal cancer: new clinical trials and experimental therapies.

Jaeckle, K., Jan 1 2005, In : Cancer Treatment and Research. 125, p. 181-193 13 p.

Research output: Contribution to journalReview article

Immunoconjugates
Investigational Therapies
Clinical Trials
Neoplasm Metastasis
Drug Therapy
53 Citations (Scopus)

Intrathecal mafosfamide: A preclinical pharmacology and phase I trial

Blaney, S. M., Balis, F. M., Berg, S., Arndt, C. A. S., Heideman, R., Geyer, J. R., Packer, R., Adamson, P. C., Jaeckle, K., Klenke, R., Aikin, A., Murphy, R., McCully, C. & Poplack, D. G., Dec 1 2005, In : Journal of Clinical Oncology. 23, 7, p. 1555-1563 9 p.

Research output: Contribution to journalArticle

Pharmacology
Headache
Pharmacokinetics
Clinical Trials, Phase I
Rhabdomyosarcoma